Antitrust & Competition Life Sciences Quarterly Update Q3 20

The third quarter in the life sciences space saw notable developments in significant agency enforcement actions: The FTC abandoned its pursuit of a novel theory and settled its Amgen/Horizon lawsuit...

Related Keywords

United States , Abbvie Allergan , Albert Bourla , Linam Khan , Pfizer Inc , United States Senate Committee , Amgen , Senate Subcommittee On , Capitol Forum , Pfizer , Novartis , Statement Of The Federal Trade Commission , Life Science Industry Coalition , Partnership To Promote Benefits Of Pro , Life Sciences Leaders , Big Pharma , Horizon Lawsuit Ends With , Horizon Therapeutics , Litmus Test , Fitzgerald Global Healthcare Conference , Big Tech , Still Worried About , Antitrust Enforcement , Draft Merger Guidelines Spur , Draft Revised Merger Guidelines , Science Ecosystem , Draft Merger , Draft Merger Guidelines , Giant Amgen , Estate Challenges , Horizon Therapeutics Acquisition , Restrict Future Acquisitions , Pursue Anticompetitive Mergers , Senate Subcommittee , Federal Trade Commission Before , States Senate Committee , Judiciary Subcommittee , Competition Policy , Consumer Rights , Antitrust Laws , Innovation Theory , Sciences Leaders , Launch New Partnership , Promote Benefits , Pro Innovation Mergers , Markets ,